Article List

WPRIM Management System> DCMS> Journal of Experimental Hematology> 2008> 16> 4

Volume: 16 Issue: 4

1. Research Progress of microRNAs and human hematological diseases - review.	Page:979—983
2. Relationship between lysophosphatide acid acyltransferase beta and tumor - review.	Page:975—978
3. Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review.	Page:969—974
4. Application of NOD/SCID mice in research of experimental hematology - review.	Page:964—968
5. Mechanisms underlying the expression regulation of HOXB4 transcription in hematopoietic stem cells - review.	Page:960—963
6. Role of NF-kappaB in hematopoietic malignancies - review.	Page:954—959
7. Recent advances of CD4(+)CD25(+) regulatory T cells in pathogenesis of idiopathic thrombocytopenic purpura - review.	Page:950—953
8. Application of fibrotic bronchoscopy in the diagnosis of pulmonary diffuse infiltration following bone marrow transplantation.	Page:946—949
9. Clinical study of bortezomib in combination with dexamethasone for the treatment of multiple myeloma.	Page:943—945
10. Treatment of chronic lymphocytic leukemia with regimen of fludarabine, cyclophosphamide and rituximab.	Page:938—942
11. Comparison between efficacy and safety of rituximab plus CHOP regimen and CHOP regimen for treatment of newly diagnosed patients with diffuse large B-cell lymphoma.	Page:933—937
12. Cryopreservation strengthens procoagulative activities of platelets.	Page:930—932
13. Application of thrombelastography in evaluation of platelet function during storage.	Page:926—929
14. Effect of highway transportation on the quality of red blood cells.	Page:922—925
15. Frequency of ABO type IgM antibody in 276 infants younger than six months.	Page:919—921
16. Expression and analysis of HLA-A, B and DRB1 genes in patients with chronic myelogenous leukemia in Guangdong area.	Page:915—918
17. Construction and expression of a fusion protein containing extracellular domain of human Jagged1 and Fc fragment of human IgG1 in Pichia Pastoris.	Page:910—914
18. Preparation of rhIL-11 from fusion protein by using enterokinase.	Page:903—909
19. Effect of dendritic cells on expansion and function of autologous natural killer cells in vitro.	Page:898—902
20. Anti-leukemia activity of T cells impacted by dendritic cells added with sodium selenite.	Page:892—897
21. Immunoregulatory effect of evodiamine in mice of various germlines.	Page:886—891
22. Hemostatic effect of hemocoagulase agkistrodon and its mechanism.	Page:883—885
23. Expression of coagulation factor IX gene mediated by human source vector pHrnF9 in intestinal epithelial sw480 cells.	Page:878—882
24. Role of CD4(+) CD25(high) T cells in the pathogenesis of idiopathic thrombocytopenic purpura.	Page:875—877
25. Expression and function of non-muscle myosin-IIA in Fechtner syndrome.	Page:871—874
26. Large scale expansion of hematopoietic progenitor cells from umbilical cord blood by magnet stirred culture system.	Page:867—870
27. Effect of bone marrow mesenchymal stem cells on T-cell subgroups.	Page:863—866
28. Effects of different doses of thrombopoietin on proliferation of bone marrow mesenchymal stem cells in mice.	Page:859—862
29. BMP-4 and VEGF promote development of hematopoietic stem cells during the embryoid body formation from embryonic stem cells.	Page:855—858
30. Mechanism of ligustrazine promoting hematopoietic reconstitution in syngenic bone marrow transplanted mice.	Page:852—854
31. Factors affecting mobilization of peripheral blood stem/progenitor cells and apheresis efficiency from healthy donors by rhG-CSF.	Page:847—851
32. Analysis of STR loci expression after allogeneic cord blood hematopoietic stem cell transplantation.	Page:843—846
33. Correlation of chemokine CCL-2/MCP-1 level in the plasma with aGVHD and idiophathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.	Page:838—842
34. Dynamic detection of chimerism and fusion gene in chronic myeloid leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation.	Page:833—837
35. Measurement of serum free light chains and its clinical significance in 20 newly diagnosed patients of multiple myeloma.	Page:829—832
36. DNA content and cell cycle analysis of myeloma cells in patients with multiple myeloma.	Page:824—828
37. Effect of decitabine combined with Trichostatin A on MDS cell line SKM-1 in vitro.	Page:819—823
38. In vitro study of biological characteristics of mesenchymal stem cells in patients with low-risk myelodysplastic syndrome.	Page:813—818
39. Mutation of mitochondria cytochrome oxidase gene in patients with myelodysplastic syndrome.	Page:809—812
40. Antiproliferative effect of curcumin combined with cyclophosmide on the growth of human lymphoma cell line HT/CTX with drug resistance and its relation with FA/BRCA pathway.	Page:804—808
41. Effect of pax5 gene blocked by RNAi on biological characteristics of B cell malignant lymphoma.	Page:799—803
42. Synergistic effects of arsenic trioxide and proteasome inhibitor bortezomib on apoptosis induction in Raji cell line.	Page:794—798
43. Protection against doxorubicin-induced oxidative damage in normal blood cells by naringenin.	Page:790—793
44. Effects of some traditional Chinese drugs on Mdr1 gene and its expression product in K562/A02 cells.	Page:785—789
45. Effect of total saponins of Panaxginseng on bax and bcl-xl gene expression in HL-60 cells.	Page:781—784
46. Suppressive effect of artesunate on K562 cell growth and its influence on VEGF expression.	Page:777—780
47. Regulatory effect of resveratrol on JAK1/STAT3 signal transduction pathway in leukemia.	Page:772—776
48. Effects of chloroquine diphosphate on proliferation and apoptosis of human leukemic K562 cells.	Page:768—771
49. Overexpression of CHIP in chronic myeloid leukemia K562 cells induces mitotic abnormality.	Page:763—767
50. Relationships of serum selenium, VEGF and sFas levels in leukemia patients.	Page:759—762
51. Expression of integrins in bone marrow mesenchymal stem cells derived from patients with chronic myeloid leukemia.	Page:755—758
52. Establishment of the methods to detect nucleophosmin gene and its mutation in acute myelogenous leukemia.	Page:750—754
53. Differential expression levels of killer immunoglobin-like receptor genotype in patients with hematological malignancies between high-risk and standard-risk groups.	Page:746—749
54. Gene expression profile of human TGF-beta signal transduction pathway of B cell type acute lymphocytic leukemia.	Page:742—745
55. Expression of a tumor related gene fgfr3 mRNA in leukemic cells and its clinical significance.	Page:738—741
56. Expression of a tumor related gene chp2 in leukemia cells.	Page:734—737
57. SphK-1/S1P signal pathway in CML cells.	Page:730—733
58. Effect of shRNA targeted to beta-catenin on K562 cell growth.	Page:725—729